Importantly, studies have demonstrated that MAPK8 exhibits significant pro-cancer effects in ovarian cancer, with MAPK8 inhibition showing notable antitumor effects both in vivo and in vitro [44]. This evidence concerns the gene MAPK8 and ovarian cancer.